ArticleEuropean heart journal. Case reports2026
Primary cardiac T-cell lymphoma presenting as ST-elevation myocardial infarction with fatal ventricular arrhythmias: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary cardiac T-cell lymphoma (PCTCL) is an extremely rare subtype of primary cardiac lymphoma. Due to the paucity of clinical data, it poses a challenge from diagnosis to management. Case summary: A 65-year-old female presented with dyspnoea and epigastric pain. Her electrocardiogram revealed an ST-elevation in leads II, III, aVF, and V4-V6, for which she underwent an emergent coronary angiogram, which revealed normal coronaries. Further multimodality cardiac imaging demonstrated a large right ventricular mass infiltrating the inferior wall of the left ventricle. A percutaneous transvenous biopsy was done, and results confirmed an anaplastic T-cell lymphoma, which prompted the initiation of chemotherapy. Unfortunately, her course became more complicated despite a notable reduction in the mass size on follow-up imaging, as she had an incessant, unstable ventricular tachycardia unresponsive to medical therapy, which led to death within 3 months of presentation. Discussion: PCTCL has unpredictable presentations. A biopsy is required to reach a definitive diagnosis, alongside multimodality cardiac imaging. Moreover, left ventricular involvement may directly influence survival in PCL and potentially indicate an advanced and fatal stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.